4//SEC Filing
Klichinsky Michael 4
Accession 0001104659-23-069498
CIK 0001485003other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 6:15 PM ET
Size
5.8 KB
Accession
0001104659-23-069498
Insider Transaction Report
Form 4
Klichinsky Michael
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-06+238,000→ 238,000 totalExercise: $7.25Exp: 2033-06-06→ Common Stock (238,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over four years, with 25% of the shares vesting on June 6, 2024 and the remaining shares vesting over the next three years thereafter in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.
Documents
Issuer
Carisma Therapeutics Inc.
CIK 0001485003
Entity typeother
Related Parties
1- filerCIK 0001967221
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 6:15 PM ET
- Size
- 5.8 KB